# Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study

> **NCT02067988** · PHASE2 · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 34 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DEVICE:** Holmium-166 microspheres hepatic radioembolization.

## Key facts

- **NCT ID:** NCT02067988
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2020-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02067988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02067988, "Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02067988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*